Autori: Geater Sarayut L
Naslov | Afatinib in locally advanced/metastatic NSCLC harboring common EGFR mutations, after chemotherapy: a Phase IV study (Article) |
Autori | Thongprasert Sumitra Geater Sarayut L Clement Dana Abdelaziz Amr Reyes-Igama Jasmin Jovanovic Dragana Alexandru Aurelia Schenker Michael Sriuranpong Virote Serwatowski Piotr Suresh Sheethal Cseh Agnieszka Gaafar Rabab |
Info | LUNG CANCER MANAGEMENT, (2019), vol. 8 br. 3, str. - |
Projekat | AstraZeneca; Roche; Boehringer Ingelheim; Novartis; Astra Zeneca; Astellas; Bristol Myers Squibb; Eli Lilly; Pfizer; AbbVie; Merck; Merck Serono; Bioven; Pharma Mar; Regeneron; Eisai; Amgern; Mylan |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |